16 Biotech Companies in NYC Strengthening the City’s Life Sciences Community
Over the past several years, New York City has taken significant measures to bolster its biotech community. In 2016, Governor Cuomo announced a $650 million initiative in an effort to to strengthen the city’s growing life sciences cluster. Alongside these efforts, VC funding for NYC's biotech sector has grown tremendously in recent years, led by organizations like NYCEDC. Recognizing the robustness of biotech hubs like San Francisco and Philadelphia, NYC is eagerly investing in its burgeoning life sciences ecosystem — and it seems to have certainly paid off.
As biotech companies continue to emerge across NYC, the city has been placed at the forefront of the nation’s life sciences scene. The city’s cluster of biotech organizations are tackling a broad range of global health issues. While one has created a smart wearable device designed to gauge sleep deprivation, another is pioneering a revolutionary new way to accelerate the discovery and treatment of cancer. There’s no question that NYC’s biotech community is rich with talent, making the city an undisputed, up-and-coming life sciences capital.
Take a look at these 16 biotech companies in NYC strengthening the city’s status as a life sciences hub.
Biotech Companies In NYC To Know
- Flatiron Health
- Imagen Technologies
- Memorial Sloan Kettering Cancer Center
- Axsome Therapeutics
Focus: Healthtech + Pharmaceutical
What they do: With over 130 years of experience, Merck has become a leader in the healthcare field. The company invests heavily in research and development, addressing issues like cancer and heart disease. Additionally, Merck has also produced vaccines through the years and has taken on the challenge of COVID-19, continuously working on antiviral efforts. New health concerns may arise, but Merck continues to lead the way with innovative solutions.
What they do: Flatiron Health aims to reinvent cancer treatment by learning from the experiences of every patient. The company’s OncoCloud suite of software and services is designed to connect community oncologists, academics, hospitals, life science researchers and regulators on a unified platform. Flatiron Health’s software capabilities include document search, automated billing, data analytics, patient identification and revenue cycle management.
What they do: Memorial Sloan Kettering Cancer Center is dedicated to discovering strategies to prevent, control and ultimately cure cancer. Utilizing agile methodologies and user-centered design, the company develops a wide range of digital products in an effort to improve the patient journey. Memorial Sloan Kettering Cancer Center aims to strengthen its testing and product development to provide greater support to patients, researchers and clinicians.
Focus: Diagnostic Care
What they do: Imagen Technologies aims to eradicate errors in radiology through its machine intelligence solution for medical diagnosis. The company is currently focused on applying AI to medical image analysis in an effort to improve patient outcomes and make diagnostic care more accessible.
Focus: Oncology + AI
What they do: Paige has developed an AI-native digital pathology ecosystem in an effort to accelerate and transform the discovery and treatment of cancer. The company’s AI suite is designed to provide pathologists, clinicians and researchers with insights drawn from decades of data diagnosed by cancer experts worldwide. Paige’s platform offers secure, scalable digital slide storage, enabling pathologists to further leverage computational pathology products as they become available for clinical use.
Focus: Diagnostic Testing
What they do: PWNHealth seeks to provide safe and easy access to diagnostic testing while empowering people to improve their health. The company’s flexible APIs and modular platform allow healthcare stakeholders to provide seamless consumer access to diagnostic testing solutions, which can be tailored for specific situations and can include clinical guidance so people can understand their results. PWNHealth’s testing solutions can be used to screen diverse populations, uncover people’s genetic risks and identify clinical trial participants.
Focus: Gut-Brain Biology
What they do: Kallyope has created a platform in an effort to unlock the therapeutic power of the gut-brain axis. The company is building a comprehensive map of gut-brain circuits and interrogating the function of these circuits in order to identify therapeutic targets that can be modulated with gut-restricted molecules. By targeting the gut-brain axis, Kallyope aims to unleash the opportunity to access and influence brain centers involved in fundamental human processes and diseases.
Focus: Gene Therapy
What they do: MeiraGTx is a clinical-stage gene therapy company dedicated to developing potentially curative treatments for patients suffering from serious diseases. The company’s gene therapy platform is primarily used for discovering new treatments for diseases of the eye, salivary gland and central nervous system. MeiraGTx currently has six programs in clinical development, which target diseases like Parkinson’s, ALS and Achromatopsia.
Focus: CNS Disorders
What they do: Axsome Therapeutics focuses on developing novel therapeutics for the treatment of central nervous systems (CNS) disorders. The company is currently focusing on discovering new treatments for disorders like Alzheimer’s, Major Depression, Narcolepsy and Fibromyalgia. Axsome has developed its own technology called MoSEIC, also called Molecular Solubility Enhanced Inclusion Complex, which creates a buffered drug-carrier complex combined with a pH modifier in order to improve the rate and degree of drug absorption.
Focus: Predictive Cardiac Physiology
What they do: TARA Biosystems seeks to reinvent predictive cardiac physiology with its proprietary platform. The company’s Biowire II platform utilizes biomimetic stimulation to produce engineered cardiac tissue, enabling the team to understand the effects of certain medicine on the heart without the need for human testing. TARA Biosystems aims to introduce a faster, safer and less costly drug development process.
Focus: Sleep Diagnostics
What they do: Tatch seeks to transform sleep diagnostics with its wearable smart patches. The company’s wireless patches enable people to perform in-home sleep tests so they can accurately determine if they have sleep apnea or other chronic disorders. Tatch’s wearable devices are capable of measuring things like movement, oxygen levels, respiratory effort and heart rates.
Focus: Cognitive Health Assessments
What they do: BrainCheck offers mobile testing for measuring cognitive health that is designed for use by both providers and individuals. Patients can take the company’s neurocognitive assessments through an online portal, which allows physicians to provide cognitive health education, remote monitoring and cognitive care management tailored to each patient’s needs. BrainCheck’s cognitive monitoring solution also allows individuals to track their brain health from home and easily share their results with loved ones.
Focus: Women’s Reproductive Health
What they do: Founded by Dr. Piraye Yurttas Beim, Celmatix is a research-stage precision health company that aims to transform women’s health. The company’s Reproductive Atlas Platform utilizes a structured dataset in an effort to develop treatments for conditions such as endometriosis and polycystic ovary syndrome (PCOS). Celmatix partners with a variety of organizations including Evotec, Bayer and the Bill & Melinda Gates Foundation.
Focus: Opioid Use Disorder Treatment
What they do: Nirsum Labs aims to combat the U.S. opioid crisis through the development of medications for opioid use disorder (OUD). The company has engineered a series of novel small molecule candidates with potential utility in OUD and other indications. Nirsum Labs’ mission is to advance the development of effective OUD treatments.
Focus: Cancer Research Trials
What they do: Massive Bio has created a platform capable of connecting cancer patients to bio-pharmaceutical trials. The company’s AI-driven platform matches patients with the right clinical research based on their cancer type and the current stage of the disease, thus helping patients discover novel treatments in real-time. Massive Bio seeks to bridge the gap between cancer patients and healthcare providers.
Focus: Personalized Wellness Solutions
What they do: LifeNome has developed an AI-driven B2B platform that allows organizations to offer their customers personalized science-based products and services. The company’s products are designed for a wide range of purposes including nutrition and diet monitoring, sleep and stress management, and genetic predisposition tracking. LifeNome partners with a variety of global organizations such as IBM, Unilever and the World Economic Forum.